Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos
Melissa Simon1, Emmanuel Cordova2, June M McKoy3
1Robert H. Lurie Comprehensive Cancer Center, Survivorship Institute, Northwestern University, Chicago, IL, 60611, USA.
Abstract:
Funded by the 21st Century Cures Act, The Beau Biden Cancer Moonshot Initiative is broad, deep, integrative, and intended to expediently address cancer's most vexing problems. Launched in 2015, it is an effort to accelerate the pace of cancer research with a focus on breaking down silos through cross-pollination of research, recruitment of multidisciplinary clinical and basic science research teams, sharing of complex scientific databases, and the creation of public-private research partnerships. This audacious approach to cancer treatment is intended to alleviate the current burden of cancer within countries and across borders. At its core is the rapid development of safe drug therapies across different disciplines through the employment of genomics, targeted proteomics with predictive analytics, and other emerging drug therapies. It will use expansive patient registries and increase early access to clinical trials. The initiative is cocooned in forward-thinking drug policies that consider the specific needs of all oncology stakeholder groups both nationally and internationally.
Insights
The Beau Biden Cancer Moonshot Initiative accelerates cancer research through collaboration and data sharing. It aims to speed up the development of safe, effective cancer therapies and improve patient access to clinical trials globally.
Area of Science:
- Oncology
- Genomics
- Proteomics
- Drug Development
Background:
- The Beau Biden Cancer Moonshot Initiative, funded by the 21st Century Cures Act, aims to accelerate cancer research.
- It focuses on breaking down research silos through collaboration and multidisciplinary teams.
Observation:
- The initiative emphasizes cross-pollination of research and sharing of complex scientific databases.
- Public-private research partnerships are a key component.
Findings:
- The core strategy involves the rapid development of safe drug therapies using genomics, targeted proteomics, and predictive analytics.
- Expansive patient registries and increased early access to clinical trials are utilized.
Implications:
- This integrative approach seeks to alleviate the global burden of cancer.
- Forward-thinking drug policies are being developed to address the needs of all oncology stakeholders internationally.
Related Concept Videos
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Curing of Concrete
Curing Methods
Accelerated Curing of Concrete
Cancer


